Chairs: Paul Lee & Ken Ho
A new pheochromocytoma syndrome: extending the phenotype associated with MAX mutations (#47)
1:00 PM
Next generation sequencing in suspected familial pituitary tumour syndromes: pilot study results and clinical translation (#48)
1:15 PM
The natural history of non-functioning pituitary adenomas: a longitudinal volumetric evaluation (#49)
1:30 PM
Somatic mutations of FOXE1 in papillary thyroid cancer (#50)
1:45 PM
Accuracy of pre-operative localisation of parathyroid adenoma with ultrasound and sestamibi scintigraphy in primary hyperparathyroidism – review of single centre experience. (#51)
2:00 PM
Positron-Emission Tomographic (PET) imaging of progesterone receptors in breast cancer: developing a predictive biomarker for tumor responsiveness to endocrine therapies (#52)
2:15 PM